GlycoMimetics ROE 2012-2020 | GLYC

Current and historical return on equity (ROE) values for GlycoMimetics (GLYC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. GlycoMimetics ROE for the three months ending June 30, 2020 was -32.31%.
GlycoMimetics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-06-30 $-0.05B $0.15B -32.52%
2020-03-31 $-0.05B $0.15B -32.10%
2019-12-31 $-0.06B $0.15B -33.48%
2019-09-30 $-0.06B $0.17B -30.65%
2019-06-30 $-0.06B $0.18B -28.18%
2019-03-31 $-0.05B $0.19B -24.17%
2018-12-31 $-0.05B $0.21B -22.05%
2018-09-30 $-0.04B $0.22B -21.89%
2018-06-30 $-0.04B $0.23B -23.02%
2018-03-31 $-0.04B $0.24B -25.43%
2017-12-31 $-0.03B $0.12B -35.11%
2017-09-30 $-0.03B $0.11B -43.99%
2017-06-30 $-0.03B $0.12B -57.14%
2017-03-31 $-0.03B $0.03B -81.01%
2016-12-31 $-0.03B $0.04B -79.50%
2016-09-30 $-0.03B $0.04B -79.52%
2016-06-30 $-0.03B $0.05B -73.99%
2016-03-31 $-0.01B $0.04B -31.28%
2015-12-31 $-0.01B $0.04B -27.66%
2015-09-30 $-0.01B $0.05B -22.11%
2015-06-30 $-0.01B $0.06B -21.15%
2015-03-31 $-0.01B $0.04B -23.96%
2014-12-31 $-0.01B $0.05B -19.30%
2014-09-30 $-0.01B $0.06B -17.78%
2014-06-30 $-0.01B $0.06B -15.50%
2014-03-31 $-0.02B $0.06B -98.46%
2013-12-31 $-0.01B $0.00B -440.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.185B $0.000B
GlycoMimetics, Inc. is a biotechnology company. The company focused on the discovery and development of novel glycomimetic drugs to address diseases in which carbohydrate biology plays a key role. It product pipeline includes GMI-170, GMI-1271, E-selectin and CXCR4 antagonist, GMI-1051 and GMI-1070 at different clinical phases. GlycoMimetics, Inc. is based in Gaithersburg, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.622B 43.60
Takeda Pharmaceutical (TAK) Japan $57.348B 9.99
Astellas Pharma (ALPMY) Japan $29.230B 14.81
UCB SA (UCBJF) Belgium $24.702B 0.00
Eisai (ESALY) Japan $24.615B 20.80
Merck (MKGAF) Germany $17.222B 22.58
Catalent (CTLT) United States $13.660B 52.81
Grifols, S.A (GRFS) Spain $12.713B 15.54
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.819B 41.88
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $7.894B 50.01
Orion OYJ (ORINY) Finland $7.077B 24.56
Jazz Pharmaceuticals (JAZZ) Ireland $7.047B 11.66
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.906B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
United Therapeutics (UTHR) United States $4.983B 11.52
Arrowhead Pharmaceuticals (ARWR) United States $4.196B 0.00
Evotec AG (EVTCY) Germany $4.113B 110.84
Hypermarcas (HYPMY) Brazil $4.097B 15.07
Nektar Therapeutics (NKTR) United States $3.829B 0.00
FibroGen (FGEN) United States $3.693B 0.00
ChemoCentryx (CCXI) United States $3.370B 0.00
PTC Therapeutics (PTCT) United States $3.183B 0.00
Sage Therapeutics (SAGE) United States $2.596B 0.00
Pacira BioSciences (PCRX) United States $2.448B 65.32
Taro Pharmaceutical Industries (TARO) Israel $2.420B 11.71
Cronos Group (CRON) Canada $2.054B 0.00
Xencor (XNCR) United States $1.833B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.791B 0.00
USANA Health Sciences (USNA) United States $1.735B 16.35
Corcept Therapeutics (CORT) United States $1.614B 14.86
Ironwood Pharmaceuticals (IRWD) United States $1.608B 11.21
Indivior (INVVY) United States $1.606B 19.93
Revolution Medicines (RVMD) United States $1.513B 0.00
Akebia Therapeutics (AKBA) United States $1.441B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.398B 13.34
Heron Therapeutics (HRTX) United States $1.391B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.315B 0.00
Zogenix (ZGNX) United States $1.311B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.138B 0.00
Karyopharm Therapeutics (KPTI) United States $1.121B 0.00
Esperion Therapeutics (ESPR) United States $1.065B 0.00
VAXART, INC (VXRT) United States $0.992B 0.00
Tilray (TLRY) Canada $0.969B 0.00
Translate Bio (TBIO) United States $0.957B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.926B 578.88
Altimmune (ALT) United States $0.848B 0.00
Endo (ENDP) Ireland $0.813B 1.20
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.706B 0.00
ImmunoGen (IMGN) United States $0.688B 0.00
Flexion Therapeutics (FLXN) United States $0.634B 0.00
Trillium Therapeutics (TRIL) Canada $0.625B 0.00
Collegium Pharmaceutical (COLL) United States $0.613B 0.00
Aerie Pharmaceuticals (AERI) United States $0.562B 0.00
Radius Health (RDUS) United States $0.539B 0.00
Siga Technologies (SIGA) United States $0.528B 0.00
Molecular Templates (MTEM) United States $0.509B 0.00
Ardelyx (ARDX) United States $0.502B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.487B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.470B 18.34
DURECT (DRRX) United States $0.467B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.459B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.455B 0.00
Ocular Therapeutix (OCUL) United States $0.451B 0.00
TherapeuticsMD (TXMD) United States $0.437B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.429B 10.36
Rigel Pharmaceuticals (RIGL) United States $0.416B 0.00
Organogenesis Holdings (ORGO) United States $0.410B 0.00
Calithera Biosciences (CALA) United States $0.353B 0.00
Harpoon Therapeutics (HARP) United States $0.319B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.318B 0.00
IMV INC (IMV) Canada $0.313B 0.00
OptiNose (OPTN) United States $0.292B 0.00
MEI Pharma (MEIP) United States $0.288B 0.00
PROFOUND MEDICL (PROF) Canada $0.286B 0.00
Redhill Biopharma (RDHL) Israel $0.282B 0.00
Concert Pharmaceuticals (CNCE) United States $0.277B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.269B 0.00
Rafael Holdings (RFL) United States $0.255B 0.00
Lannett Co Inc (LCI) United States $0.248B 5.44
CASI Pharmaceuticals (CASI) United States $0.230B 0.00
Aquestive Therapeutics (AQST) United States $0.204B 0.00
KalVista Pharmaceuticals (KALV) United States $0.200B 0.00
Nivalis Therapeutics (ALPN) United States $0.199B 0.00
Nature's Sunshine Products (NATR) United States $0.196B 25.82
Taiwan Liposome (TLC) Taiwan $0.194B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.187B 0.00
Onconova Therapeutics (ONTX) United States $0.180B 0.00
Heat Biologics (HTBX) United States $0.179B 0.00
Jounce Therapeutics (JNCE) United States $0.163B 3.90
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.141B 0.00
Xeris Pharmaceuticals (XERS) United States $0.120B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.117B 0.00
MediWound (MDWD) Israel $0.113B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Otonomy (OTIC) United States $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Biomerica (BMRA) United States $0.104B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.103B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.103B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.100B 0.00
CTI BioPharma (CTIC) United States $0.098B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.097B 0.00
Recro Pharma (REPH) United States $0.097B 0.00
Hemispherx BioPharma (AIM) United States $0.095B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.094B 0.00
Lipocine (LPCN) United States $0.092B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.091B 0.00
ElectroCore (ECOR) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.082B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
CV Sciences (CVSI) United States $0.068B 0.00
Addex Therapeutics (ADXN) Switzerland $0.064B 0.00
PolarityTE (PTE) United States $0.062B 0.00
Sundial Growers (SNDL) Canada $0.060B 0.00
Infinity Pharmaceuticals (INFI) United States $0.059B 0.00
Novan (NOVN) United States $0.053B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.82
AgeX Therapeutics (AGE) United States $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.046B 0.00
Natural Alternatives (NAII) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
GTx (ONCT) United States $0.044B 0.00
IsoRay (ISR) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.043B 8.16
Entasis Therapeutics Holdings (ETTX) United States $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 83.09
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Can-Fite Biopharma (CANF) Israel $0.034B 0.00
India Globalization Capital (IGC) United States $0.029B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
Vical (BBI) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 35.29
Shineco (TYHT) China $0.015B 0.00
China SXT Pharmaceuticals (SXTC) China $0.014B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00